COMMUNICATIONS
Newman, D. Lucent, J. H. Ryan, G. P. Savage, C. L.
Francis, J. J. Deadman, Antivir. Chem. Chemother. 2011,
21, 155–168; f) J. S. Franzone, R. Cirillo, C. Cravanzola,
Eur. J. Med. Chem. 1983, 18, 261–267; g) S. Messaoudi,
M. Sancelme, V. Polard-Housset, B. Aboab, P. Moreau,
M. Prudhomme, Eur. J. Med. Chem. 2004, 39, 453–458.
[2] a) K. E. Coffey, R. Moreira, F. Z. Abbas, G. K. Murphy,
Org. Bio. Chem. 2015, 13, 682–685; b) G. K. Murphy,
F. Z. Abbas, A. V. Poulton, Adv. Synth. Catal. 2014,
356, 2919–2923; c) H. Hamamoto, H. Umemoto, M.
Umemoto, C. Ohta, E. Fujita, A. Nakamura, T. Meaga-
wa, Y. Miki, Heterocycles 2015, 91, 561–572; d) H. Ha-
mamoto, H. Umemoto, M. Umemoto, C. Ohta, M.
Dohshita, Y. Miki, Synlett 2010, 2593–2596; e) C. Hep-
ples, G. K. Murphy, Tetrahedron Lett. 2015, 56, 4971–
4974.
[3] a) A. Nakazaki, K. Miyagawa, N. Miyata, T. Nishikawa,
Eur. J. Org. Chem. 2015, 4603–4606; b) S. Rossiter, Tet-
rahedron Lett. 2002, 43, 4671–4673; c) E. A. Kraynack,
J. E. Dalgard, F. C. A. Gaeta, Tetrahedron Lett. 1998,
39, 7679–7682.
[4] a) M. Abelman, N. Chu, R. Jiang, J. Zablocki, WO
Patent WO2011056985 A3, 2010; b) A. N. C. Lçtter, R.
Pathak, T. S. Sello, M. A. Fernandes, W. A. L. van Ot-
terlo, C. B. de Konig, Tetrahedron 2007, 63, 2263–2274.
[5] a) Y. Jiang, T. V. Hansen, Bioorg. Med. Chem. Lett.
2011, 21, 1626–1629; b) D. Lee, S. A. Long, WO Patent
WO1999006042 A1, 1999; c) W. Liu, H.-M. Zhu, G.-J.
Niu, E.-Z. Shi, J. Chen, B. Sun, W.-Q. Chen, H.-G.
Zhou, C. Yang, Bioorg. Med. Chem. 2014, 22, 292–302.
[6] D. V. Kravchenko, J. A. Kuzovkova, V. M. Kysil, S. E.
Tkachenko, S. Malarchuk, I. M. Okun, A. V. Ivachtch-
enko, Lett. Drug Des. Discovery 2006, 3, 61–70.
[8] For NCS-mediated oxidation, please see: a) J. Einhorn,
C. Einhorn, R. Ratajczak, J.-L. Pierre, J. Org. Chem.
1996, 61, 7452–7454; b) K. S. Kim, I. H. Cho, B. K. Yoo,
Y. H. Song, C. S. Hahn, J. Chem. Soc. Chem. Commun.
1984, 762–763; c) K. Takaki, M. Yasumura, K. Negoro,
J. Org. Chem. 1983, 48, 54–57.
[9] For NBS-mediated oxidation, please see: a) D. Xu, S.
Wang, Z. Shen, C. Xia, W. Sun, Org. Biomol. Chem.
2012, 10, 2730–2732; b) N. S. Krishnaveni, K. Surendra,
K. R. Rao, Adv. Synth. Catal. 2004, 346, 346–350; c) R.
Filler, Chem. Rev. 1963, 63, 21–43; d) E. A. Coula-
douros, M. P. Georgiadis, J. Org. Chem. 1986, ##51##61,
2725–2727; e) B. W. Finucane, J. B. Thomson, J. Chem.
Soc. Perkin Trans. 1 1972, 1856–1862; f) L. F. Fieser,
W. P. Schneider, W.-Y. Huang, J. Am. Chem. Soc. 1953,
75, 124–127; g) E. J. Corey, M. Ishiguro, Tetrahedron
Lett. 1998, 39, 7679–7682.
[10] Selected examples of the decarboxylative effect of hal-
ogen sources: a) L. Candish, E. A. Standley, A.
Gomez-Suarez, S. Mukherjee, F. Glorius, Chem. Eur. J.
2016, 22, 9971–9974; b) A. Kamal, M. Sathish, A. V. G.
Prasanthi, J. Chetna, Y. Tangella, V. Srinivasulu, N.
Shankaraiah, A. Alarifi, RCS Adv. 2015, 5, 90121–
90126; c) F. G. Bordwell, M. D. Wolfinger, J. B.
OꢀDwyer, J. Org. Chem. 1974, 39, 2516–2519; d) J. P.
Das, S. Roy, J. Org. Chem. 2002, 67, 7861–7864; e) D.
Naskar, S. Chowdhury, S. Roy, Tetrahedron Lett. 1998,
39, 699–702; f) K. Kulbitski, G. Nisnevich, M. Gandel-
man, Adv. Synth. Catal. 2011, 353, 1438–1442.
[11] X. Jiang, J. Yang, F. Zhang, P. Yu, P. Ying, Y. Sun, Y.
Wang, Adv. Synth. Catal. 2016, 358, 2678.
[12] For the optimization of the bromination–decarboxyla-
tion–oxidation, please see the Supporting Information.
[7] S. Dolci, F. Marchetti, G. Pampaloni, S. Zacchini,
Dalton Trans. 2013, 42, 5635–5648.
Adv. Synth. Catal. 0000, 000, 0 – 0
5
ꢁ 2016 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
ÞÞ
These are not the final page numbers!